Why Piper Sandler Shares Are Trading Higher Today

Piper Sandler sees a surge in shares as it surpasses Q4 expectations with $471.85 million in sales and $4.03 adjusted EPS. The company declared a special cash dividend of $1.00 per share and a quarterly cash dividend of $0.60 per share.

Piper Sandler Companies (NYSE:PIPR) shares are trading higher after the company reported better-than-expected fourth-quarter results.

Piper Sandler reported Q4 sales of $471.85 million, beating the Wall Street Estimate of $370.12 million. Sales jumped 21% year over year.

The company reported adjusted EPS of $4.03, exceeding the analyst’s view of $2.60.

Advisory services revenues of $284.3 million for the quarter, representing the second strongest quarter on record, the company said.

Corporate financing revenues of $30.2 million fell 18% year over year due to fewer completed deals. 

For the fourth quarter, non-interest expenses jumped 11% compared to the fourth quarter of 2022.

Adjusted operating income was $99.1 million, up 31% year over year, with an adjusted operating margin of 21.7%, higher than 19.3% in the year-ago quarter. 

Special Dividend: The company declared a special cash dividend on the company’s common stock of $1.00 per share to be paid on March 15, 2024.

In addition, the firm declared a quarterly cash dividend on the company’s common stock of $0.60 per share.

Price Action: PIPR shares are trading higher by 5.81% to $187.65 on the last check Friday.

Total
0
Shares
Related Posts
Read More

Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly

Biohaven's approach to combat obesity. Learn about their experimental drug taldefgrobep alfa (t-alpha), targeting muscle growth regulation for effective weight loss. CEO Vlad Coric discusses its potential to preserve muscle mass, boost metabolism, and induce weight loss.

BHVN